Biggest News Aggregation in the World
๐Ÿ“ฐ Classification Committee News

Page 5 - Classification Committee News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Classification Committee. Real-time updates on events, politics, business and more.

Teva announces promising interim results from its study PEARL, about the impact of AJOVY® (fremanezumab)

Interim data presented at the European Academy of Neurology 2022 shows that 54.7% of patients in the study had their monthly-migraine-days reduced by 50% or more over the six-month period from the start of treatment.
Messoud Ashina Faisal Mohammad Amin Danilo Lembo Rigshospitalet Glostrup Eurolight Steering Committee University Of Copenhagen

Teva Pharmaceutical Industries Ltd.: Teva Announces Promising Interim Results From Its Study PEARL, About the Impact of AJOVY (fremanezumab)

Interim data presented at the European Academy of Neurology 2022 shows that 54.7% of patients in the study had their monthly-migraine-days reduced by 50% or more over the six-month period from the start
Messoud Ashina Faisal Mohammad Amin Danilo Lembo Rigshospitalet Glostrup Fiona Cohen Eurolight Steering Committee

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News โ†’

USM looks to adjust pay scales following $15 minimum wage

To address wage compression caused by the University System of Maryland raising its minimum wage to $15, the system is planning to adjust nonexempt staff pay scales. Nonexempt, hourly positions within the USM are sorted into โ€œpay gradeโ€ categories that denote the minimum amount that role can be paid, the maximum it can be paid, and ...
United States College Park University Of Maryland Stuart Katzenberg Tim Curtis Mike Lurie

AbbVie Announces Positive Phase 3 Atogepant (QULIPTA™) Data for the Preventive Treatment of Chronic Migraine

NORTH CHICAGO, Ill., March 10, 2022 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced that the Phase 3 PROGRESS trial evaluating atogepant (QULI...
United States American Migraine Foundation Drug Administration International Classification Of Headache Disorders Exchange Commission International Burden Of Migraine Study

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science